All In Biotech

Drug Trial Radar · NCT01262456

Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients

A Multi-centre, Randomised, Double-blind, Placebo-controlled, Parallel-group Trial With an Open-label Extension to Demonstrate the Efficacy and Safety of Desmopressin Orally Disintegrating Tablets for the Treatment of Nocturia in Adult Males

Last checked: Nov 19, 2026Latest source record: Oct 15, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 395 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

395

Actual

Start

Feb 2011

Primary completion

Jan 2012

Study completion Jan 2012

Sponsor

Lead sponsor
Ferring PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Dec 17, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this trial was to confirm/establish long-term safety and efficacy of desmopressin orally disintegrating tablets at dose levels of 50 μg and 75 μg and to further evaluate the safety of an efficacious higher dose level of 100 μg in males with nocturia.

Conditions

  • Nocturia

Interventions

  • DesmopressinDrug

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Mean Number of Nocturnal Voids Averaged Over a 3-Month PeriodTime frame: Day 1 (Baseline), Week 1, Months 1, 2, 3 (3-month double-blind treatment period)
  2. Adjusted Probability of Participants Achieving a >33% Reduction From Baseline in Number of Nocturnal Voids for All During-Treatment Visits up to Month 3Time frame: Day 1 (Baseline), Week 1, Months 1, 2, 3 (3-month double-blind treatment period)

Locations

56 sites in 2 countries. Site status is shown where the registry gives one.

  • Pinnacle Research Group, LLC

    Anniston, Alabama

  • Medical Affiliated Research Center, Inc.

    Huntsville, Alabama

  • Radiant Research, Inc.

    Scottsdale, Arizona

  • Premiere Pharmaceutical Research

    Tempe, Arizona

  • Family Medical Center

    Foothill Rance, California

  • Axis Clinical Trials

    Los Angeles, California

  • Radiant Research, Inc.

    Santa Rosa, California

  • Genitourinary Surgical Consultants

    Denver, Colorado

  • Radiant Research, Inc.

    Denver, Colorado

  • Front Range Clinical Research, LLC

    Wheat Ridge, Colorado

  • Connecticut Clinical Research Center, LLC

    Middlebury, Connecticut

  • South Florida Medical Research

    Aventura, Florida

  • Women's Medical Research Group, LLC

    Clearwater, Florida

  • Avail Clinical Research, LLC

    DeLand, Florida

  • FPA Clinical Research

    Kissimmee, Florida

  • Sunrise Medical Research

    Lauderdale Lakes, Florida

  • Advanced Pharma CR, LLC

    Miami, Florida

  • DMI Research

    Pinellas Park, Florida

  • Pinellas Urology, Inc

    St. Petersburg, Florida

  • Midtown Medical Center

    Tampa, Florida

  • Advanced Research Institute, Inc.

    Trinity, Florida

  • Radiant Research, Inc.

    Atlanta, Georgia

  • Southeastern Medical Research Institute

    Columbus, Georgia

  • Radiant Research, Inc.

    Chicago, Illinois

  • Accelovance

    Peoria, Illinois

  • Accelovance

    South Bend, Indiana

  • FutureCare Studies, Inc.

    Springfield, Massachusetts

  • Bay State Clinical Trials, Inc.

    Watertown, Massachusetts

  • Beyer Research

    Kalmazoo, Michigan

  • Radiant Research, Inc.

    Edina, Minnesota

  • Radiant Research, Inc.

    St Louis, Missouri

  • Radiant Research

    Las Vegas, Nevada

  • Anderson & Collins Clinical Research Inc.

    Edison, New Jersey

  • Urology Center Research Institute

    Englewood, New Jersey

  • AccuMed Research Associates

    Garden City, New York

  • University Urology Associates

    New York, New York

  • Radiant Research, Inc.

    Akron, Ohio

  • Community Research

    Cincinnati, Ohio

  • Complete HealthCare

    Columbus, Ohio

  • Urologic Consultants of SE PA

    Bala-Cynwyd, Pennsylvania

Showing 40 of 56 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.